described an overall poor compliance to AOM, with patients on liraglutide displaying a greater adherence compared to orlistat, phentermine/topiramate, and naltrexone/bupropion 50
Tirzepatide comes in pre-filled injection pens with weekly dosing at 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg strengths, with established dosing protocols from extensive Phase 3 trials
Handle only in a controlled laboratory setting
(2023, April 17)
Adisorn had been dealing with persistent acne and dark blemishes and had previously sought treatments at other clinics but felt that his skin concerns remained
We thank Chloe ALDEBERT and Sylvain MORINEAU for the help with the experimental work, Emeline HUPKENS, Pascale JESPERS for support with the laboratory analyses